TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 5 March 3, 2014
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 5 March 3, 2014
(The next issue will be on March 18, 2014)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ISTH also maintains a list of upcoming meetings of
interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1xmXzoKy-fPeqHzorDHfhaq/
Agerso H, Overgaard RV, Petersen MB, Hansen L, Hermit MB, Sorensen MH, . . . Hilden I (2014) Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus Monkeys after iv and sc administration. Eur J Pharm Sci.
http://www.ncbi.nlm.nih.gov/pubmed/24568891
Batorova A, Mariani G, Kavakli K, de Saez AR, Caliskan U, Karimi M, . . . Ingerslev J (2014) Inhibitors to factor VII in congenital factor VII deficiency. Haemophilia 20:e188-191.
http://www.ncbi.nlm.nih.gov/pubmed/24533960
Colace TV, Tormoen GW, McCarty OJ, Diamond SL (2013) Microfluidics and coagulation biology. Annu Rev Biomed Eng 15:283-303.
http://www.ncbi.nlm.nih.gov/pubmed/23642241
Cordazzo C, Neri T, Petrini S, Lombardi S, Balia C, Cianchetti S, . . . Celi A (2013) Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway. Thromb Res 131:e168-174.
http://www.ncbi.nlm.nih.gov/pubmed/23414567
Ellery PE, Maroney SA, Martinez ND, Wickens MP, Mast AE (2014) Translation of human tissue factor pathway inhibitor-beta mRNA is controlled by alternative splicing within the 5' untranslated region. Arterioscler Thromb Vasc Biol 34:187-195.
http://www.ncbi.nlm.nih.gov/pubmed/24233486
Geddings JE, Mackman N (2014) New players in haemostasis and thrombosis. Thromb Haemost 111.
http://www.ncbi.nlm.nih.gov/pubmed/24573314
Ghinea N, Lipworth W, Kerridge I, Little M, Day RO (2014) Ethics and Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. Hastings Cent Rep.
http://www.ncbi.nlm.nih.gov/pubmed/24532448
Iwase H, Ezzelarab MB, Ekser B, Cooper DK (2014) The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options. Xenotransplantation.
http://www.ncbi.nlm.nih.gov/pubmed/24571124
Lin ZM, Zhao JX, Duan XN, Zhang LB, Ye JM, Xu L, Liu YH (2014) Effects of Tissue Factor, PAR-2 and MMP-9 Expression on Human Breast Cancer Cell Line MCF-7 Invasion. Asian Pac J Cancer Prev 15:643-646.
http://www.ncbi.nlm.nih.gov/pubmed/24568471
Parker RI (2014) Transfusion in critically ill children: indications, risks, and challenges. Crit Care Med 42:675-690.
http://www.ncbi.nlm.nih.gov/pubmed/24534955
Perzborn E, Heitmeier S, Laux V, Buchmuller A (2014) Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/24529498
Sakamoto T, Kudoh T, Sakamoto K, Matsui K, Ogawa H (2014) Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study. Hypertens Res.
http://www.ncbi.nlm.nih.gov/pubmed/24572913
Sridharan V, Tripathi P, Sharma S, Corry PM, Moros EG, Singh A, . . . Boerma M (2013) Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS One 8:e68762.
http://www.ncbi.nlm.nih.gov/pubmed/23894340
Stephan F, Marsman G, Bakker LM, Bulder I, Stavenuiter F, Aarden LA, Zeerleder S (2014) Cooperation of Factor VII-Activating Protease and Serum DNase I in the Release of Nucleosomes From Necrotic Cells.
Arthritis Rheumatol 66:686-693.
http://www.ncbi.nlm.nih.gov/pubmed/24574229
Wood JP, Ellery PE, Maroney SA, Mast AE (2014) Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-alpha but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 34:169-176.
http://www.ncbi.nlm.nih.gov/pubmed/24233490
Wu X, Du Z, Yu J, Sun Y, Pei B, Lu X, . . . Hu J (2014) Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury. J Trauma Acute Care Surg 76:114-120.
http://www.ncbi.nlm.nih.gov/pubmed/24368365
Zhang B, Wang H, Liao Z, Wang Y, Hu Y, Yang J, . . . Jiang X (2014) EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma. Biomaterials.
http://www.ncbi.nlm.nih.gov/pubmed/24529623
Agerso H, Overgaard RV, Petersen MB, Hansen L, Hermit MB, Sorensen MH, . . . Hilden I (2014) Pharmacokinetics of an anti-TFPI monoclonal antibody (concizumab) blocking the TFPI interaction with the active site of FXa in Cynomolgus Monkeys after iv and sc administration. Eur J Pharm Sci.
http://www.ncbi.nlm.nih.gov/pubmed/24568891
Batorova A, Mariani G, Kavakli K, de Saez AR, Caliskan U, Karimi M, . . . Ingerslev J (2014) Inhibitors to factor VII in congenital factor VII deficiency. Haemophilia 20:e188-191.
http://www.ncbi.nlm.nih.gov/pubmed/24533960
Colace TV, Tormoen GW, McCarty OJ, Diamond SL (2013) Microfluidics and coagulation biology. Annu Rev Biomed Eng 15:283-303.
http://www.ncbi.nlm.nih.gov/pubmed/23642241
Cordazzo C, Neri T, Petrini S, Lombardi S, Balia C, Cianchetti S, . . . Celi A (2013) Angiotensin II induces the generation of procoagulant microparticles by human mononuclear cells via an angiotensin type 2 receptor-mediated pathway. Thromb Res 131:e168-174.
http://www.ncbi.nlm.nih.gov/pubmed/23414567
Ellery PE, Maroney SA, Martinez ND, Wickens MP, Mast AE (2014) Translation of human tissue factor pathway inhibitor-beta mRNA is controlled by alternative splicing within the 5' untranslated region. Arterioscler Thromb Vasc Biol 34:187-195.
http://www.ncbi.nlm.nih.gov/pubmed/24233486
Geddings JE, Mackman N (2014) New players in haemostasis and thrombosis. Thromb Haemost 111.
http://www.ncbi.nlm.nih.gov/pubmed/24573314
Ghinea N, Lipworth W, Kerridge I, Little M, Day RO (2014) Ethics and Evidence in Medical Debates: The Case of Recombinant Activated Factor VII. Hastings Cent Rep.
http://www.ncbi.nlm.nih.gov/pubmed/24532448
Iwase H, Ezzelarab MB, Ekser B, Cooper DK (2014) The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options. Xenotransplantation.
http://www.ncbi.nlm.nih.gov/pubmed/24571124
Lin ZM, Zhao JX, Duan XN, Zhang LB, Ye JM, Xu L, Liu YH (2014) Effects of Tissue Factor, PAR-2 and MMP-9 Expression on Human Breast Cancer Cell Line MCF-7 Invasion. Asian Pac J Cancer Prev 15:643-646.
http://www.ncbi.nlm.nih.gov/pubmed/24568471
Parker RI (2014) Transfusion in critically ill children: indications, risks, and challenges. Crit Care Med 42:675-690.
http://www.ncbi.nlm.nih.gov/pubmed/24534955
Perzborn E, Heitmeier S, Laux V, Buchmuller A (2014) Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/24529498
Sakamoto T, Kudoh T, Sakamoto K, Matsui K, Ogawa H (2014) Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study. Hypertens Res.
http://www.ncbi.nlm.nih.gov/pubmed/24572913
Sridharan V, Tripathi P, Sharma S, Corry PM, Moros EG, Singh A, . . . Boerma M (2013) Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS One 8:e68762.
http://www.ncbi.nlm.nih.gov/pubmed/23894340
Stephan F, Marsman G, Bakker LM, Bulder I, Stavenuiter F, Aarden LA, Zeerleder S (2014) Cooperation of Factor VII-Activating Protease and Serum DNase I in the Release of Nucleosomes From Necrotic Cells.
Arthritis Rheumatol 66:686-693.
http://www.ncbi.nlm.nih.gov/pubmed/24574229
Wood JP, Ellery PE, Maroney SA, Mast AE (2014) Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-alpha but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 34:169-176.
http://www.ncbi.nlm.nih.gov/pubmed/24233490
Wu X, Du Z, Yu J, Sun Y, Pei B, Lu X, . . . Hu J (2014) Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury. J Trauma Acute Care Surg 76:114-120.
http://www.ncbi.nlm.nih.gov/pubmed/24368365
Zhang B, Wang H, Liao Z, Wang Y, Hu Y, Yang J, . . . Jiang X (2014) EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma. Biomaterials.
http://www.ncbi.nlm.nih.gov/pubmed/24529623
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
